Kontraktstillverkaren Hanza levererar ytterligare ett starkt kvartal där Huvudmarknader lyfter lönsa...
Vi inleder bevakning av MindArk PE (”MindArk” eller ”Bolaget”), ett svenskt underhållningsbolag som ...
Svag ARR-tillväxt, men stark marginal Omsättningen i kvartalet uppgick till 36,7 mkr, vilket motsvar...
Redeye comments on Sleep Cycle's Q2 2023 report, which was in line with our estimates.
Redeye updates its estimates on Safeture following the Q2 2023 report.
Redeye updates on Stillfront following the company’s Q2-results where revenue was close to our expec...
Svagt Q2-resultat Nettoomsättningen sjönk med 21% y/y till 793 mkr (1 009) och justerat EBIT uppgick...
- We raise '23e-'25e EBITA by 1% - Cash flow beat: three for three - '24e-'25e lease adj.
Ahead of NoHo's Q2 report, we incorporate the announced acquisition of Holy Cow! to our estimates.
Redeye takes a positive stance towards Hanza following a solid Q2 report, with the strong margin in ...
• Solid Q2'23, providing confidence to upgrade FY'23.
• Q2e: 25.9% y-o-y ARR growth; expect reiterated guidance • Demand likely still weak, with few or no...
• Clean EBITDA SEK 23m vs. ABGSCe SEK 22m • Decided to close its sawmill in Estonia.
The outcome of the rights issue has been announced and it includes that approximately 74% have been ...
Following today's unexpected news of the discontinued deal with Bausch + Lomb, Redeye is providing i...
We expect XVIVO to initiate the US study during early Q4 2023 and the inclusion of donation after ci...
• Organic growth of 13% vs. ABGSCe 16% • Adj. EBITA SEK 141m, 9% above ABGSCe • We expect cons.
Redeye sees a strong Q2 from Hanza, with the exceptional EBITA margin of 11.
Ahead of CapMan's Q2 report, due on 3 August, our SOTP-based fair value range of EUR 2.
We expect relatively good Q2 results, but H2 2023 estimates include a lot of uncertainty due to a ma...
